Skip to content

PHARMEDIC

Active
Private limited companyfounded 20187 yrs activeRue du Fays 1, 5336 Assesse, BelgiumKBO/BCE: BE 0715.682.133
Summary

The computed 12-month bankruptcy probability of PHARMEDIC is 2.6% (moderate). The 2025 annual accounts show equity of €129,921 and a net result of €54,336. Equity is growing by ~18.8% per year across the filed fiscal years. Its solvency ranks better than 15% of 1910 sector peers (fiscal year 2025). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes · tick = 2024
Profitability62▲+11
Solvency35▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
2.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €6,000 at 30 days acceptable
Liquidity tight (current ratio 1.01 against 0.94 in 2024; short-term debt: 27.4% and cash: 4.4% of total assets), and 89.9% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 7 years 0 10 y
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 25
Relative position
BE, all sectors
reference
Manufacture of fabricated metal products, except machinery and equipment (NACE 25)
about 50% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
10.1%
Return on assets
4.2%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 1910 sector peers (2025).
NBB · sector comparison
Position among 1910 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filings
Deviation from the deadline
2025
26 d late
2024
60 d late
2023
61 d late
2022
31 d late
2021
31 d late
2020
30 d late
2019
31 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 39 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 35% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
26-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 11 December 2018, PHARMEDIC was incorporated.1 Total assets went from EUR 207,721 in 2019 to EUR 1.3 million in 2025 and headcount from 2 to 0.9 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€129,921▲ 71.9%
2024 · €75,585
Total assets
€1.3m▼ 0.3%
2024 · €1.3m
Net result
€54,336▲ 189%
2024 · €18,777
Working capital
€5,100
2024 · -€21,273
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€5,811▼ 40.5%€11,339▲ 95.1%€19,928▲ 75.8%€57,144▲ 187%€109,203▲ 91.1%
Net result€4,441▼ 40.9%€10,286▲ 132%€1,594▼ 84.5%€18,777▲ 1,078%€54,336▲ 189%
Equity€44,929▲ 11.0%€55,214▲ 22.9%€56,808▲ 2.9%€75,585▲ 33.1%€129,921▲ 71.9%
Total assets€151,059▲ 2.8%€183,165▲ 21.3%€1.3m▲ 607%€1.3m▼ 0.5%€1.3m▼ 0.3%
Debt€106,131▼ 0.3%€127,950▲ 20.6%€1.2m▲ 868%€1.2m▼ 2.0%€1.2m▼ 4.8%
Working capital€22,057▲ 74.1%€33,269▲ 50.8%-€12,003-€21,273▼ 77.2%€5,100
Staff (FTE)2.9▲ 38.1%3.1▲ 6.9%2▼ 35.5%0.5▼ 75.0%0.9▲ 80.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000Operating result 2021: €5,811€5,811Net result 2021: €4,441€4,441Operating result 2022: €11,339€11,339Net result 2022: €10,286€10,286Operating result 2023: €19,928€19,928Net result 2023: €1,594€1,594Operating result 2024: €57,144€57,144Net result 2024: €18,777€18,777Operating result 2025: €109,203€109,203Net result 2025: €54,336€54,33620212022202320242025€0€50,000€100,000Operating result 2023: €19,928€19,900Net result 2023: €1,594€1,590Operating result 2024: €57,144€57,100Net result 2024: €18,777€18,800Operating result 2025: €109,203€109,000Net result 2025: €54,336€54,300202320242025
The operating result has risen four years in a row; 2025 is 91% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.3m
Fixed assets €927,829 ▼ 4.3%
Current assets €356,868 ▲ 11.6%
Equity and liabilities €1.3m
Equity €129,921 ▲ 71.9%
Debt €1.2m ▼ 4.8%
Debt's share of the balance-sheet total falls from 94.1% to 89.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€188,181▲
2024 · €131,352
Cash flow
€133,315▲
2024 · €92,985
Current ratio
1.01▲
2024 · 0.94
Quick ratio
0.42▼
2024 · 0.46
Debt to equity
8.89▼
2024 · 16.05
ROE
41.8%▲
2024 · 24.8%
ROA
4.2%▲
2024 · 1.5%
Interest coverage
4.50▲
2024 · 3.60
Debt ≤ 1 year
€351,768▲
2024 · €340,975
Debt > 1 year
€803,008▼
2024 · €872,395
Income taxes
€13,167▲
2024 · €1,870
Staff costs
€34,009▲
2024 · €29,163
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 53 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.3m€1.3m▼
Fixed assets21/28€969,253€927,829▼
Intangible fixed assets21€162,661€143,500▼
Tangible fixed assets22/27€806,591€784,329▼
Land and buildings22€702,345€709,016▲
Plant, machinery and equipment23€45,040€34,137▼
Furniture and vehicles24€59,207€41,176▼
Current assets29/58€319,702€356,868▲
Stocks and contracts in progress3€163,384€210,245▲
Stocks30/36€163,384€210,245▲
Amounts receivable within one year40/41€54,167€87,242▲
Trade receivables40€35,646€62,279▲
Other amounts receivable41€18,521€24,963▲
Cash at bank and in hand54/58€100,486€57,121▼
Deferred charges and accrued income490/1€1,666€2,261▲
Equity and liabilities
Total equity and liabilities10/49€1.3m€1.3m▼
Equity10/15€75,585€129,921▲
Contributions10/11€18,600€18,600=
Reserves13€26,920€81,256▲
Non-distributable reserves130/1€720€720=
Reserves not available under the articles1311€720€720=
Distributable reserves133€26,200€80,536▲
Profit (loss) carried forward14€30,065€30,065=
Amounts payable17/49€1.2m€1.2m▼
Amounts payable after more than one year17€872,395€803,008▼
Financial debts170/4€872,395€803,008▼
Amounts payable within one year42/48€340,975€351,768▲
Current portion of amounts payable after more than one year42€74,436€70,429▼
Financial debts43€6,757€6,732▼
Credit institutions430/8€6,757€6,732▼
Trade debts44€20,557€47,536▲
Suppliers440/4€20,557€47,536▲
Taxes, remuneration and social security45€4,761€9,109▲
Taxes450/3€2,006€3,682▲
Remuneration and social security454/9€2,754€5,427▲
Other amounts payable47/48€234,465€217,962▼
Income statement Code20242025
Remuneration, social security and pensions62€29,163€34,009▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€74,208€78,978▲
Other operating charges640/8€1,904€1,733▼
Gross operating margin9900€162,418€223,924▲
Operating profit (loss)9901€57,144€109,203▲
Financial income75/76B-€81
Recurring financial income75-€81
Financial charges65/66B€36,497€41,781▲
Recurring financial charges65€36,497€41,781▲
Profit (loss) for the period before taxes9903€20,647€67,503▲
Income taxes67/77€1,870€13,167▲
Profit (loss) for the period9904€18,777€54,336▲
Profit (loss) for the period to be appropriated9905€18,777€54,336▲
Appropriation of the result
Profit (loss) to be appropriated9906€48,765€84,401▲
Profit (loss) brought forward from the previous period14P€29,988€30,065▲
Transfer to equity691/2€18,700€54,336▲
To other reserves6921€18,700€54,336▲

The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€71,378€81,550€73,422€29,163€34,009▲ 16.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€26,826€22,941€85,767€74,208€78,978▲ 6.4%
Other operating charges640/8€309€164€768€1,904€1,733▼ 9.0%
Gross operating margin9900€104,324€115,994€179,884€162,418€223,924▲ 37.9%
Operating profit (loss)9901€5,811€11,339€19,928€57,144€109,203▲ 91.1%
Financial income75/76B€1-€581-€81-
Recurring financial income75€1-€581-€81-
Financial charges65/66B€1,372€1,053€18,915€36,497€41,781▲ 14.5%
Recurring financial charges65€1,372€1,053€18,915€36,497€41,781▲ 14.5%
Profit (loss) for the period before taxes9903€4,441€10,286€1,594€20,647€67,503▲ 227%
Income taxes67/77---€1,870€13,167▲ 604%
Profit (loss) for the period9904€4,441€10,286€1,594€18,777€54,336▲ 189%
Profit (loss) for the period to be appropriated9905€4,441€10,286€1,594€18,777€54,336▲ 189%
Line20212022202320242025Change
Assets
Total assets20/58€151,059€183,165€1.3m€1.3m€1.3m▼ 0.3%
Fixed assets21/28€46,735€23,793€976,044€969,253€927,829▼ 4.3%
Intangible fixed assets21€3,354€1,496€182,419€162,661€143,500▼ 11.8%
Tangible fixed assets22/27€43,381€22,297€793,625€806,591€784,329▼ 2.8%
Land and buildings22--€721,213€702,345€709,016▲ 0.9%
Plant, machinery and equipment23€23,545€11,754€6,910€45,040€34,137▼ 24.2%
Furniture and vehicles24€19,835€10,543€65,502€59,207€41,176▼ 30.5%
Current assets29/58€104,325€159,371€318,961€319,702€356,868▲ 11.6%
Stocks and contracts in progress3€35,000€68,400€145,983€163,384€210,245▲ 28.7%
Stocks30/36--€109,183€163,384€210,245▲ 28.7%
Contracts in progress37€35,000€68,400€36,800---
Amounts receivable within one year40/41€59,907€84,509€50,539€54,167€87,242▲ 61.1%
Trade receivables40€59,611€84,213€46,013€35,646€62,279▲ 74.7%
Other amounts receivable41€296€296€4,526€18,521€24,963▲ 34.8%
Cash at bank and in hand54/58€8,502€3,306€117,486€100,486€57,121▼ 43.2%
Deferred charges and accrued income490/1€916€3,156€4,953€1,666€2,261▲ 35.7%
Equity and liabilities
Total equity and liabilities10/49€151,059€183,165€1.3m€1.3m€1.3m▼ 0.3%
Equity10/15€44,929€55,214€56,808€75,585€129,921▲ 71.9%
Contributions10/11€18,600€18,600€18,600€18,600€18,600=
Reserves13€8,220€8,220€8,220€26,920€81,256▲ 202%
Non-distributable reserves130/1€720€720€720€720€720=
Reserves not available under the articles1311€720€720€720€720€720=
Distributable reserves133€7,500€7,500€7,500€26,200€80,536▲ 207%
Profit (loss) carried forward14€18,109€28,394€29,988€30,065€30,065=
Amounts payable17/49€106,131€127,950€1.2m€1.2m€1.2m▼ 4.8%
Amounts payable after more than one year17€23,863€1,848€907,232€872,395€803,008▼ 8.0%
Financial debts170/4€23,863€1,848€907,232€872,395€803,008▼ 8.0%
Amounts payable within one year42/48€82,268€126,102€330,964€340,975€351,768▲ 3.2%
Current portion of amounts payable after more than one year42€21,730€22,015€58,936€74,436€70,429▼ 5.4%
Financial debts43---€6,757€6,732▼ 0.4%
Credit institutions430/8---€6,757€6,732▼ 0.4%
Trade debts44€32,860€65,210€50,578€20,557€47,536▲ 131%
Suppliers440/4€32,860€65,210€50,578€20,557€47,536▲ 131%
Taxes, remuneration and social security45€22,917€7,017€7,522€4,761€9,109▲ 91.3%
Taxes450/3€11,109-€629€2,006€3,682▲ 83.5%
Remuneration and social security454/9€11,809€7,017€6,894€2,754€5,427▲ 97.1%
Other amounts payable47/48€4,761€31,861€213,927€234,465€217,962▼ 7.0%
Line20212022202320242025Change
Profit (loss) for the period9904€4,441€10,286€1,594€18,777€54,336▲ 189%
+ Depreciation and write-downs630€26,826€22,941€85,767€74,208€78,978▲ 6.4%
Operating cash flow (approximation)€31,267€33,227€87,360€92,985€133,315▲ 43.4%
Investment in fixed assets (approximation)-€0-€1.0m-€67,417-€37,554▲ 44.3%
Change in cash--€5,196€114,180-€17,001-€43,365▼ 155%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 26 days late
2025
31-12
Financial Highest result since 2019net €54,336 ▲189%
Operating result €109,203, net result €54,336, both a record.
31-12
Financial Equity above €100,000Eq €129,921 ▲71.9%
7 profitable years in a row build equity to €129,921.
29-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 60 days late
2024
30-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 61 days late
2023
31-12
Financial Weakest financial yearnet €1,594 ▼84.5%
Net result drops to €1,594, the lowest in the series; recovery starts the following year.
31-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
30-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
31-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Assesse · 3 establishment units since 2018
seat establishment All 3 establishment units on the map
Ground area
1.3 ha
Building footprint
555 m²
3 parcels, Wallonia. Linked by address, not a title deed.
3 establishment units
STEEL & MORE
Chaussée d'Eghezée, Meux 46, 5081 La BruyèreManufacture of fabricated metal products, except machinery and equipment
since 20182.282.785.033
STEEL & MORE
Rue des Cortys, Hempt. 12, 5380 FernelmontOther business support services
since 20222.339.827.862
Pharma Courrière
Rue du Fays 1, 5336 AssesseManufacture of basic pharmaceutical products and pharmaceutical preparations
since 20232.346.335.572
3 parcels
Wallonia 3 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92088B0140/00T000 Wallonia 9,474 m² 1 · 216 m² -
92063B0076/00H000 Wallonia 2,369 m² 1 · 146 m² -
92028A0513/00H005 Wallonia 1,240 m² 1 · 193 m² -
Linked by address, not proof of ownership
Good to know
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 980 companies in sector 25401 we hold annual accounts for 407. 322 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded11-12-2018
Fiscal year end31-12
Trade name FR STEEL & MORE / PHARMACOURRIERE
Activities, NACEBEL 2025
25401Forging of metal
47730Retail sale of pharmaceutical products
Contact
E-mail info@steelandmore.be
Phone +32474860277
Phone +3281479124Assesse
E-invoicing
Reachable via Peppol
Peppol ID 0208:0715682133
Also 9925:BE0715682133
Registered 18-01-2026

Register as of 26 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.